Prilosec Granule, Delayed Release
Product Images NDC 70515-610

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Prilosec (NDC 70515-610). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Covis Pharma Us, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Omeprazole Structural Formula (Image 01)

Chemical structure of omeprazole magnesium, the active ingredient in Prilosec. The structure shows the molecular arrangement including the magnesium ion (Mg2+) complexed with two omeprazole molecules.*

FDA Label Image

Omeprazole Magnesium Structural Formula (Image 02)

Prilosec 2.5 mg omeprazole magnesium delayed-release oral suspension carton label. The package contains 30 single-dose child-resistant packets. The label includes dosing preparation instructions and storage information. The product is labeled for prescription use only and is manufactured by Covis Pharma US, Inc.*

FDA Label Image

Principal Display Panel (2.5 mg Label)

Prilosec 10 mg delayed-release oral suspension granules packaging label from Covis Pharma US, Inc. The label indicates a carton containing 30 single-dose child-resistant packets, each with 10 mg omeprazole magnesium. Includes dosing instructions and storage information. The label shows branding, dosage strength, and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.